NH - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:03 am

IntraDay Trade Rating: 3.6

📊 Analysis: NH is trading at ₹1,926, above both DMA 50 (₹1,868) and DMA 200 (₹1,759), showing medium-term strength. RSI at 42.7 indicates neutral momentum, not strongly oversold or overbought. MACD (-0.38) is slightly negative, suggesting mild weakness intraday. Volume (2.71 lakh) is in line with average (2.69 lakh), showing stable participation. With high P/E (84.7) compared to industry PE (51.8), valuation looks stretched, but strong ROE (21%) and ROCE (19.4%) support fundamentals. Intraday potential exists but requires cautious entry.

💡 Optimal Buy Price: ₹1,915–₹1,925 (near support zone)

🎯 Profit-Taking Exit Levels: ₹1,945–₹1,955 (short-term bounce target)

🛑 Stop-Loss / Loss Protection: ₹1,905 (below immediate support)

⏱️ If Already Holding: Exit intraday if price fails to sustain above ₹1,925 or if RSI drops below 40 with MACD staying negative. Consider booking profits if price approaches ₹1,945–₹1,955 with volume confirmation.

✅ Positive

• 📈 Strong ROE at 21% and ROCE at 19.4%
• 📊 EPS at ₹22.7 supports valuation strength
• 📈 Quarterly PAT improved to ₹138 Cr. vs ₹87.4 Cr. (30.6% growth)
• 📊 Trading above DMA 50 and DMA 200 indicates medium-term strength

⚠️ Limitation

• 📉 High P/E ratio (84.7) compared to industry PE (51.8)
• 📊 RSI at 42.7 shows neutral momentum, limiting upside
• 📉 Debt-to-equity ratio at 0.69 is moderately high
• 📊 MACD slightly negative, showing weak intraday momentum

🚨 Company Negative News

• 📉 DII holding reduced by -0.33%, showing domestic investor caution
• 📊 Valuation stretched relative to industry peers

🌟 Company Positive News

• 📈 Quarterly profit growth (+30.6%) supports earnings momentum
• 📊 FII holding increased slightly (+0.03%), showing foreign investor confidence

🏭 Industry

• 📊 Industry PE at 51.8, lower than NH’s 84.7, suggesting overvaluation
• ⚡ Healthcare sector outlook tied to demand growth and regulatory environment

📌 Conclusion

NH shows moderate intraday potential today. Fundamentals are strong with profit growth and efficiency ratios, but stretched valuation and weak intraday momentum limit upside. Traders may attempt entries near ₹1,915–₹1,925 with stop-loss at ₹1,905 and profit booking around ₹1,945–₹1,955. Conservative traders should wait for stronger momentum confirmation before entering intraday positions.

Would you like me to extend this into a peer benchmarking overlay comparing NH with other healthcare sector stocks, so you can identify relative intraday strength opportunities?